378 related articles for article (PubMed ID: 15494207)
1. Sumoylation of internally initiated Sp3 isoforms regulates transcriptional repression via a Trichostatin A-insensitive mechanism.
Spengler ML; Kennett SB; Moorefield KS; Simmons SO; Brattain MG; Horowitz JM
Cell Signal; 2005 Feb; 17(2):153-66. PubMed ID: 15494207
[TBL] [Abstract][Full Text] [Related]
2. The modification of Sp3 isoforms by SUMOylation has differential effects on the SRC1A promoter.
Ellis DJ; Dehm SM; Bonham K
Gene; 2006 Sep; 379():68-78. PubMed ID: 16781829
[TBL] [Abstract][Full Text] [Related]
3. Sumoylation inhibits cleavage of Sp1 N-terminal negative regulatory domain and inhibits Sp1-dependent transcription.
Spengler ML; Brattain MG
J Biol Chem; 2006 Mar; 281(9):5567-74. PubMed ID: 16407261
[TBL] [Abstract][Full Text] [Related]
4. Sp3 represses gene expression via the titration of promoter-specific transcription factors.
Kennett SB; Moorefield KS; Horowitz JM
J Biol Chem; 2002 Mar; 277(12):9780-9. PubMed ID: 11773047
[TBL] [Abstract][Full Text] [Related]
5. Ubc9 interacts with chicken ovalbumin upstream promoter-transcription factor I and represses receptor-dependent transcription.
Kobayashi S; Shibata H; Kurihara I; Yokota K; Suda N; Saito I; Saruta T
J Mol Endocrinol; 2004 Feb; 32(1):69-86. PubMed ID: 14765993
[TBL] [Abstract][Full Text] [Related]
6. Identification of Daxx interacting with p73, one of the p53 family, and its regulation of p53 activity by competitive interaction with PML.
Kim EJ; Park JS; Um SJ
Nucleic Acids Res; 2003 Sep; 31(18):5356-67. PubMed ID: 12954772
[TBL] [Abstract][Full Text] [Related]
7. Repression of Smad4 transcriptional activity by SUMO modification.
Long J; Wang G; He D; Liu F
Biochem J; 2004 Apr; 379(Pt 1):23-9. PubMed ID: 14750902
[TBL] [Abstract][Full Text] [Related]
8. Role for SUMO modification in facilitating transcriptional repression by BKLF.
Perdomo J; Verger A; Turner J; Crossley M
Mol Cell Biol; 2005 Feb; 25(4):1549-59. PubMed ID: 15684403
[TBL] [Abstract][Full Text] [Related]
9. ZNF198, a zinc finger protein rearranged in myeloproliferative disease, localizes to the PML nuclear bodies and interacts with SUMO-1 and PML.
Kunapuli P; Kasyapa CS; Chin SF; Caldas C; Cowell JK
Exp Cell Res; 2006 Nov; 312(19):3739-51. PubMed ID: 17027752
[TBL] [Abstract][Full Text] [Related]
10. SUMO-1 modification represses Sp3 transcriptional activation and modulates its subnuclear localization.
Ross S; Best JL; Zon LI; Gill G
Mol Cell; 2002 Oct; 10(4):831-42. PubMed ID: 12419227
[TBL] [Abstract][Full Text] [Related]
11. Trichostatin A, a histone deacetylase inhibitor, activates the IGFBP-3 promoter by upregulating Sp1 activity in hepatoma cells: alteration of the Sp1/Sp3/HDAC1 multiprotein complex.
Choi HS; Lee JH; Park JG; Lee YI
Biochem Biophys Res Commun; 2002 Aug; 296(4):1005-12. PubMed ID: 12200149
[TBL] [Abstract][Full Text] [Related]
12. Activation of the p21WAF1/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites.
Huang L; Sowa Y; Sakai T; Pardee AB
Oncogene; 2000 Nov; 19(50):5712-9. PubMed ID: 11126357
[TBL] [Abstract][Full Text] [Related]
13. Nucleus accumbens associated 1 is recruited within the promyelocytic leukemia nuclear body through SUMO modification.
Tatemichi Y; Shibazaki M; Yasuhira S; Kasai S; Tada H; Oikawa H; Suzuki Y; Takikawa Y; Masuda T; Maesawa C
Cancer Sci; 2015 Jul; 106(7):848-56. PubMed ID: 25891951
[TBL] [Abstract][Full Text] [Related]
14. SUMO-1 modification of the Wilms' tumor suppressor WT1.
Smolen GA; Vassileva MT; Wells J; Matunis MJ; Haber DA
Cancer Res; 2004 Nov; 64(21):7846-51. PubMed ID: 15520190
[TBL] [Abstract][Full Text] [Related]
15. Sp1 trans-activation of cell cycle regulated promoters is selectively repressed by Sp3.
Birnbaum MJ; van Wijnen AJ; Odgren PR; Last TJ; Suske G; Stein GS; Stein JL
Biochemistry; 1995 Dec; 34(50):16503-8. PubMed ID: 8845379
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional regulation of mouse mu opioid receptor gene: Sp3 isoforms (M1, M2) function as repressors in neuronal cells to regulate the mu opioid receptor gene.
Choi HS; Hwang CK; Kim CS; Song KY; Law PY; Wei LN; Loh HH
Mol Pharmacol; 2005 May; 67(5):1674-83. PubMed ID: 15703380
[TBL] [Abstract][Full Text] [Related]
17. Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors.
Lin DY; Huang YS; Jeng JC; Kuo HY; Chang CC; Chao TT; Ho CC; Chen YC; Lin TP; Fang HI; Hung CC; Suen CS; Hwang MJ; Chang KS; Maul GG; Shih HM
Mol Cell; 2006 Nov; 24(3):341-54. PubMed ID: 17081986
[TBL] [Abstract][Full Text] [Related]
18. Regulation of nuclear receptor and coactivator functions by the carboxyl terminus of ubiquitin-conjugating enzyme 9.
Chang YL; Huang CJ; Chan JY; Liu PY; Chang HP; Huang SM
Int J Biochem Cell Biol; 2007; 39(5):1035-46. PubMed ID: 17336575
[TBL] [Abstract][Full Text] [Related]
19. SUMO-1 modification of PIASy, an E3 ligase, is necessary for PIASy-dependent activation of Tcf-4.
Ihara M; Yamamoto H; Kikuchi A
Mol Cell Biol; 2005 May; 25(9):3506-18. PubMed ID: 15831457
[TBL] [Abstract][Full Text] [Related]
20. Sp1 and Sp3 transcription factors mediate trichostatin A-induced and basal expression of extracellular superoxide dismutase.
Zelko IN; Folz RJ
Free Radic Biol Med; 2004 Oct; 37(8):1256-71. PubMed ID: 15451065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]